Activation and regulation of Toll-like receptors 2 and 1 in human leprosy (original) (raw)
Brightbill, H.D. et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science285, 732–736 (1999). ArticleCASPubMed Google Scholar
Aliprantis, A.O. et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science285, 736–739 (1999). ArticleCASPubMed Google Scholar
Takeuchi, O. et al. Role of TLR1 in mediating immune response to microbial lipoproteins. J. Immunol.169, 10–14 (2002). ArticleCASPubMed Google Scholar
Alexopoulou, L. et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med.8, 878–884 (2002). ArticleCASPubMed Google Scholar
Alexopoulou, L., Holt, A.C., Medzhitov, R. & Flavell, R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature413, 732–738 (2001). ArticleCASPubMed Google Scholar
Yang, R.B. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature395, 284–288 (1998). ArticleCASPubMed Google Scholar
Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science282, 2085–2088 (1998). ArticleCASPubMed Google Scholar
Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity11, 443–451 (1999). ArticleCASPubMed Google Scholar
Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll- like receptor 5. Nature410, 1099–1103 (2001). ArticleCASPubMed Google Scholar
Takeuchi, O. et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol.13, 933–940 (2001). ArticleCASPubMed Google Scholar
Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88- dependent signaling pathway. Nat. Immunol.3, 196–200 (2002). ArticleCASPubMed Google Scholar
Jurk, M. et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol.3, 499 (2002).
Hemmi, H. et al. A Toll-like receptor that recognizes bacterial DNA. Nature408, 740–745 (2000). ArticleCASPubMed Google Scholar
Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A.J. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature388, 394–397 (1997). ArticleCASPubMed Google Scholar
Thoma-Uszynski, S. et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science291, 1544–1547 (2001). ArticleCASPubMed Google Scholar
Ridley, D.S. & Jopling, W.H. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr.34, 255–273 (1966). CAS Google Scholar
Yamamura, M. et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science254, 277–279 (1991). ArticleCASPubMed Google Scholar
Salgame, P. et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science254, 279–282 (1991). ArticleCASPubMed Google Scholar
Staege, H., Schaffner, A. & Schneemann, M. Human toll-like receptors 2 and 4 are targets for deactivation of mononuclear phagocytes by interleukin-4. Immunol. Lett.71, 1–3 (2000). ArticleCASPubMed Google Scholar
Sieling, P.A. et al. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J. Immunol.153, 3639–3647 (1994). CASPubMed Google Scholar
Garcia, V.E. et al. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J. Immunol.162, 6114–6121 (1999). CASPubMed Google Scholar
Flo, T.H. et al. Differential expression of Toll-like receptor 2 in human cells. J. Leukoc. Biol.69, 474–481 (2001). CASPubMed Google Scholar
O'Brien, A.D. et al. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J. Immunol.124, 20–24 (1980). CASPubMed Google Scholar
Anderson, G.W.J. & Osterman, J.V. Host defenses in experimental rickettsialpox: genetics of natural resistance to infection. Infect. Immun.28, 132–136 (1980). PubMedPubMed Central Google Scholar
Cross, A. et al. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J. Clin. Invest.96, 676–686 (1995). ArticleCASPubMedPubMed Central Google Scholar
Weinstein, D.L., Lissner, C.R., Swanson, R.N. & O'Brien, A.D. Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice. Cell. Immunol.102, 68–77 (1986). ArticleCASPubMed Google Scholar
Medina, E. & North, R.J. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology93, 270–274 (1998). ArticleCASPubMedPubMed Central Google Scholar
Takeuchi, O., Hoshino, K. & Akira, S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol.165, 5392–5396 (2000). ArticleCASPubMed Google Scholar
Wang, X. et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol.168, 810–815 (2002). ArticleCASPubMed Google Scholar
Wooten, R.M. et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol.168, 348–355 (2002). ArticleCASPubMed Google Scholar
Kang, T.J. & Chae, G.T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol.31, 53–58 (2001). ArticleCASPubMed Google Scholar
Aliprantis, A.O., Yang, R.B., Weiss, D.S., Godowski, P. & Zychlinsky, A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J.19, 3325–3336 (2000). ArticleCASPubMedPubMed Central Google Scholar
Cole, S.T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature393, 537–544 (1998). ArticleCASPubMed Google Scholar
Post, F.A. et al. Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits _Mycobacterium smegmatis_-induced cytokine production by human macrophages in vitro. Infect. Immun.69, 1433–1439 (2001). ArticleCASPubMedPubMed Central Google Scholar
Yeremeev, V.V. et al. Deletion of the 19kDa antigen does not alter the protective efficacy of BCG. Tubercle Lung Dis.80, 243–247 (2000). ArticleCAS Google Scholar
Means, T.K. et al. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol.163, 3920–3927 (1999). CASPubMed Google Scholar
Means, T.K. et al. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol.163, 6748–6755 (1999). CASPubMed Google Scholar
Hirschfeld, M., Ma, Y., Weis, J.H., Vogel, S.N. & Weis, J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol.165, 618–622 (2000). ArticleCASPubMed Google Scholar
Takeuchi, O. et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol.164, 554–557 (2000). ArticleCASPubMed Google Scholar
Monney, L. et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature415, 536–541 (2002). ArticleCASPubMed Google Scholar
Modlin, R.L. et al. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J. Immunol.132, 3085–3090 (1984). CASPubMed Google Scholar
Stenger, S. et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science282, 121–125 (1998). ArticleCASPubMed Google Scholar
Ochoa, M.T. et al. T-cell release of granulysin contributes to host defense in leprosy. Nat. Med.7, 174–179 (2001). ArticleCASPubMed Google Scholar